Approved for Treatment of moderate to severe osteoarthritis pain, Treatment of chronic low back pain (investigational in some markets). Monoclonal antibody that binds nerve growth factor (NGF), preventing it from activating pain signaling through TrkA receptors. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…